Therapeutic Goods (Listing) Notice 2009 (No. 2)
Federal Register of Legislative Instruments (FRLI): Legislative Instrument - F2009L03483 (11 September 2009)
Note: If you intend to rely on any legislation referred to on this website, you should access copies of the official versions on the Attorney General's Department's ComLaw website <http://www.comlaw.gov.au> (incorporating the Federal Register of Legislative Instruments (FRLI)). Instruments are amended from time to time and may, on occasions, be replaced or new instruments made.
COMMONWEALTH OF AUSTRALIA
Therapeutic Goods Act 1989
I, ROHAN HAMMETT, National Manager, Therapeutic Goods Administration, delegate of the Minister for Health and Ageing for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 (the Act) and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods (the ARTG) for listed goods:
- preparations for the purposes Item 3 of Part 1 of Schedule 4 of the Regulations for oral use that contain, as their therapeutically active ingredient, sodium citrate.
AND
- preparations for the purposes Item 3 of Part 1 of Schedule 4 of the Regulations for oral use that contain, as their therapeutically active ingredient, sodium acid citrate.
This Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.
Pursuant to subsection 9A(6) of the Act this Notice ceases to have effect on the day that amendments to the Regulations come into effect to require inclusion of the therapeutic goods listed in this Notice in the part of the ARTG for listed goods.
Dated this 1st day of September 2009
Rohan Hammett
Delegate of the Minister for Health and Ageing